Skip to main content
NIH funding notice PAS-10-151

Grants for Alzheimers Disease Drug Discovery (R21)

Closed on May 7, 2013.

Posted
March 22, 2010
Close date
May 7, 2013
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $233,581 in first-year total cost, median $233,581.

Most frequent study sections

  1. Drug Discovery for the Nervous System Study Section[DDNS]1

Most frequent institutions

  1. UNIVERSITY OF ILLINOIS AT CHICAGO1
Competing awards under PAS-10-151 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014Potential ApoE Isoform-Specific Detrimental Effects of RXR Agonists in Alzheimer'1R21AG044682-01A1LADU, MARY JOTHATCHER, GREGORY R. JUNIVERSITY OF ILLINOIS AT CHICAGO, IL$233,581DDNS

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAS-10-151: Grants for Alzheimers Disease Drug Discovery (R21) | ScienceDex | ConductScience